Table 4. Pre-surgical patient, tumor and treatment characteristics elderly versus non-elderly.
| Characteristics | ≤69 years (N=77), n (%) | ≥70 years (N=57), n (%) | P value |
|---|---|---|---|
| Mean age (±SD) | 60±8.1 | 75±3.6 | <0.001* |
| Mean BMI (±SD) (kg/m2) | 28±5 | 28±4.6 | 0.96 |
| Sex | 0.97 | ||
| Male | 61 (79.2) | 45 (78.9) | |
| Female | 16 (20.8) | 12 (21.1) | |
| Race | 0.23 | ||
| Caucasian | 74 (96.1) | 52 (91.2) | |
| Black | 3 (3.9) | 3 (5.3) | |
| Other | 0 (0) | 2 (3.5) | |
| Tumor location | 0.07 | ||
| Cervical | 0 (0) | 1 (1.8) | |
| Upper & mid-thoracic | 6 (7.8) | 0 (0) | |
| Lower thoracic & GE junction | 59 (76.6) | 50 (87.7) | |
| Unknown | 12 (15.6) | 6 (10.5) | |
| Tumor histology | 0.51 | ||
| Adenocarcinoma | 66 (85.7) | 49 (86.0) | |
| Squamous | 7 (9.1) | 7 (12.3) | |
| Other | 4 (5.2) | 1 (1.8) | |
| Median clinical tumor size (range) (cm) | 3 (0.7-10) | 2.6 (0.1-9) | 0.44 |
| Clinical T stage | 0.3 | ||
| 1 | 19 (24.7) | 19 (33.3) | |
| 2 | 10 (13.0) | 7 (12.3) | |
| 3 | 43 (55.8) | 24 (42.1) | |
| 4 | 1 (1.3) | 0 (0) | |
| Unknown | 4 (5.2) | 7 (12.3) | |
| Clinical N stage | 0.07 | ||
| 0 | 27 (35.1) | 28 (49.1) | |
| 1 | 39 (50.6) | 17 (29.8) | |
| 2 | 4 (5.2) | 2 (3.5) | |
| Unknown | 7 (9.1) | 10 (17.5) | |
| Neoadjuvant treatment | 65 (84.4) | 37 (64.9) | 0.01* |
*, denotes significant P value; SD, standard deviation; GE, gastroesophageal.